Biodistribution of charged F(ab')2 photoimmuno-conjugates in a xenograft model of ovarian cancer
1997

Biodistribution of Charged Photoimmunoconjugates in Ovarian Cancer

Sample size: 12 publication Evidence: moderate

Author Information

Author(s): LR Duskal, MR Hamblin, MP Bamberg, T Hasan

Primary Institution: Harvard Medical School, Massachusetts General Hospital

Hypothesis

The study investigates how charge modification of photoimmunoconjugates affects their biodistribution in a xenograft model of ovarian cancer.

Conclusion

Cationic photoimmunoconjugates showed higher tumor selectivity and uptake compared to anionic ones in a model of ovarian cancer.

Supporting Evidence

  • Cationic OC125F(ab')2 photoimmunoconjugates had the highest tumor selectivity.
  • At 3 hours, cationic conjugates delivered significantly more photosensitizer to tumors than anionic ones.
  • Statistical analysis showed significant differences in biodistribution between cationic and anionic conjugates.

Takeaway

This study found that positively charged treatments work better at targeting ovarian cancer cells than negatively charged ones.

Methodology

The study involved injecting radiolabelled photoimmunoconjugates into mice and measuring their distribution in tumor and normal tissues.

Limitations

The study did not address the penetration depth of the photosensitizer into tumor nodules.

Participant Demographics

Female Swiss nude mice, 6-8 weeks old.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication